Research & KnowledgeEvent: September 1, 2026
Cool Flame Bio is moving into its formal human clinical trials.
Published
Signal category
Research & Knowledge
Quote
“These are the questions before us as we move into our formal human clinical trials at Cool Flame Bio.”
— Vicken Karageozian|Cool Flame Bio team
Company
Cool Flame Bio
Bringing Neurosalvage to Neuropathy.
- Industry
- Biotechnology Research
- Company size
- 1 employees
Cool Flame Bio is developing a synthetic peptide platform CFB-001. It is designed to protect mitochondrial structure and function in sensory neurons and protect these neurons from chemotherapy induced damage.
Founded 2026